Assistant
Ask
Navigate
Command

Cytophage Technologies Ltd. CYTO.V

Cytophage Technologies Ltd. is a Canadian biotechnology company specializing in bacteriophage research, product development, and commercialization, headquartered in Winnipeg, Manitoba. The company develops precision phage therapeutics to combat antibiotic-resistant bacterial infections across human health, animal health, and food security applications. Cytophage has received Canadian regulatory approvals and successfully treated patients with its bacteriophage therapies targeting difficult-to-treat prosthetic joint infections.

Key ratios
ReturnOnAssets TTM -0.6
ReturnOnAssets 2024 -0.62
ReturnOnAssets 2023 -0.69
ReturnOnEquity TTM -1.71
ReturnOnEquity 2024 -4.76
ReturnOnEquity 2023 -2.42
Recent news
Cytophage Announces Filings Under the BIA 2026-05-22 · Stockhouse
Cytophage Announces Departure of Chief Operating Officer 2026-04-14 · TheNewsWire
Cytophage Announces Formation of Special Committee of Independent Directors to Evaluate Strategic Alternatives 2026-03-06 · TheNewsWire
Cytophage Announces Operational Restructuring 2026-02-19 · TheNewsWire
An unhandled error has occurred. Reload 🗙